ILDSTAD SUZANNE (Chief Scientific Officer) sold 0.5% of their position (15K shares) of TOURMALINE BIO, INC. on the open market
Open‑market sale worth $35.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/25/2023ACC: 0001209191-23-025602
DirectorOfficer10% Owner· Chief Scientific Officer
Since May 2021
-15K
Net shares
Net seller
$35.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15K
Price / share
$2.35
Trade value
$35.23K
% of position
0.5%
4/21/2023
2.84M→2.82M
Total
Net shares
−15K
Net value
-$35.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/21/2023 | S · Sale | −15K | $2.35 | $35.23K | 0.5% | 2.84M | 2.82M |
| Total | −15K | -$35.23K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned654.21K
Common Stock
IndirectShares owned1.20M
Common Stock
IndirectShares owned654.21K
Total
2.51M indirect2.51M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 654.21K | Indirect |
| Common Stock | 1.20M | Indirect |
| Common Stock | 654.21K | Indirect |
| Total | 2.51M | 2.51M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported